Ana Cañete
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ana Cañete has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Antonio M. Garcia-Ortega
Centro Andaluz de Biología del Desarrollo (CABD), CSIC, Universidad Pablo de Olavide, Seville, Spain
1 shared publicationBenjamin Dekel
Department of Pediatrics and Pediatric Stem Cell Research Institute, Edmond and Lili Safra Children's Hospital, Chaim Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
1 shared publication- Berthold Göttgens
Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK
1 shared publication Cristina Quinter
Centro Andaluz de Biología del Desarrollo (CABD), CSIC, Universidad Pablo de Olavide, Seville, Spain
1 shared publicationElena Cano
Integrative Vascular Biology Lab, Max Delbrück Center for Molecular Medicine, Robert-Rössle-Str. 10, 13092, Berlin, Germany
1 shared publicationLaura Ariza
University of Málaga, Faculty of Science, Department of Animal Biology, Málaga, Spain
1 shared publication
Latest Publications
- 28 December 2015
- Published by Wiley in Developmental Dynamics
- Vol. 245 (3) , 307-322
Coelomic epithelium‐derived cells in visceral morphogenesis
Coelomic cavities of vertebrates are lined by a mesothelium which develops from the lateral plate mesoderm. During development, the coelomic epithelium is a highly active cell layer, which locally is able to supply mesenchymal cells that contribute to the mesodermal elements of many organs and provide signals which are necessary for their development. The relevance of this process of mesenchymal cell supply to the developing organs is becoming clearer because genetic lineage tracing techniques have been developed in recent years. Body wall, heart, liver, lungs, gonads, and gastrointestinal tract are populated by cells derived from the coelomic epithelium which contribute to their connective and vascular tissues, and sometimes to specialized cell types such as the stellate cells of the liver, the Cajal interstitial cells of the gut or the Sertoli cells of the testicle. In this review we collect information about the contribution of coelomic epithelium derived cells to visceral development, their developmental fates and signaling functions. The common features displayed by all these processes suggest that the epithelial–mesenchymal transition of the embryonic coelomic epithelium is an underestimated but key event of vertebrate development, and probably it is shared by all the coelomate metazoans. Developmental Dynamics 245:307–322, 2016.
- 28 December 2015
- Published by Wiley in Developmental Dynamics
- Vol. 245 (3) , 307-322
Coelomic epithelium‐derived cells in visceral morphogenesis
Coelomic cavities of vertebrates are lined by a mesothelium which develops from the lateral plate mesoderm. During development, the coelomic epithelium is a highly active cell layer, which locally is able to supply mesenchymal cells that contribute to the mesodermal elements of many organs and provide signals which are necessary for their development. The relevance of this process of mesenchymal cell supply to the developing organs is becoming clearer because genetic lineage tracing techniques have been developed in recent years. Body wall, heart, liver, lungs, gonads, and gastrointestinal tract are populated by cells derived from the coelomic epithelium which contribute to their connective and vascular tissues, and sometimes to specialized cell types such as the stellate cells of the liver, the Cajal interstitial cells of the gut or the Sertoli cells of the testicle. In this review we collect information about the contribution of coelomic epithelium derived cells to visceral development, their developmental fates and signaling functions. The common features displayed by all these processes suggest that the epithelial–mesenchymal transition of the embryonic coelomic epithelium is an underestimated but key event of vertebrate development, and probably it is shared by all the coelomate metazoans. Developmental Dynamics 245:307–322, 2016.
- Open Access
- 25 September 2009
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 28 (1) , 100-112
Enhanced Hematovascular Contribution of SCL 3′ Enhancer Expressing Fetal Liver Cells Uncovers Their Potential to Integrate in Extramedullary Adult Niches
Fetal liver (FL) hematopoietic progenitors have superior blood engraftment competence compared with adult bone marrow (BM), however less is known about FL in vivo vascular capacity. Here we show in transplantation assays that FL cells possess enhanced vascular endothelial potential compared with adult bone marrow. We generated high‐level hematopoietic chimeras using donor cells from mice transgenic for the stem cell leukaemia 3′ enhancer human placental alkaline phosphatase (SCL3′Enh‐PLAP) reporter construct, active in vascular endothelium, and blood progenitor and stem cells. Long‐term lineage tracing analysis revealed PLAP+ vascular‐like patches in FL‐derived chimeras, whereas adult BM‐derived chimeras presented only rare and scattered PLAP+ cells. PLAP+ vascular‐like patches were formed following transplantation into both newborn and adult recipient mice, although their frequency was reduced in adult recipients. Confocal analysis of multiple labeled tissues revealed that whereas most liver and heart PLAP+ vascular patch‐associated cells were endothelial, PLAP+ vascular patches in the kidney contained endothelial, hematopoietic, and putative hemangioblastic cells. Moreover, fluorescence‐activated cell sorting assays showed that only FL PLAPbright+ donor cells can generate PLAP+ vascular patches upon transplantation. Taken together, these data demonstrate superior vascular contribution potential of FL cells, and not only provide new insights into the developmental pathways controlling endothelial development but also may prove informative when addressing the mechanisms involved in vascular regeneration and hemangiogenic recovery in a clinical context. STEM CELLS 2010;28:100–112
- 25 September 2009
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 28 (1) , 100-112
Open AccessEnhanced Hematovascular Contribution of SCL 3′ Enhancer Expressing Fetal Liver Cells Uncovers Their Potential to Integrate in Extramedullary Adult Niches
Fetal liver (FL) hematopoietic progenitors have superior blood engraftment competence compared with adult bone marrow (BM), however less is known about FL in vivo vascular capacity. Here we show in transplantation assays that FL cells possess enhanced vascular endothelial potential compared with adult bone marrow. We generated high‐level hematopoietic chimeras using donor cells from mice transgenic for the stem cell leukaemia 3′ enhancer human placental alkaline phosphatase (SCL3′Enh‐PLAP) reporter construct, active in vascular endothelium, and blood progenitor and stem cells. Long‐term lineage tracing analysis revealed PLAP+ vascular‐like patches in FL‐derived chimeras, whereas adult BM‐derived chimeras presented only rare and scattered PLAP+ cells. PLAP+ vascular‐like patches were formed following transplantation into both newborn and adult recipient mice, although their frequency was reduced in adult recipients. Confocal analysis of multiple labeled tissues revealed that whereas most liver and heart PLAP+ vascular patch‐associated cells were endothelial, PLAP+ vascular patches in the kidney contained endothelial, hematopoietic, and putative hemangioblastic cells. Moreover, fluorescence‐activated cell sorting assays showed that only FL PLAPbright+ donor cells can generate PLAP+ vascular patches upon transplantation. Taken together, these data demonstrate superior vascular contribution potential of FL cells, and not only provide new insights into the developmental pathways controlling endothelial development but also may prove informative when addressing the mechanisms involved in vascular regeneration and hemangiogenic recovery in a clinical context. STEM CELLS 2010;28:100–112